Quick Answer
Akebia Therapeutics, Inc. reported Common Stock Shares Outstanding of 265.42 million shares for the year ending 2025.
- Akebia Therapeutics, Inc. showed an increase of +18.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Akebia Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Akebia Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 19,087.2%.
- Historical annual values: Fiscal year 2025: 265.42 million shares | Fiscal year 2024: 224.85 million shares | Fiscal year 2023: 194.58 million shares | Fiscal year 2022: 184.14 million shares | Fiscal year 2021: 177.00 million shares | Fiscal year 2020: 148.07 million shares | Fiscal year 2019: 121.67 million shares | Fiscal year 2018: 116.89 million shares | Fiscal year 2017: 47.61 million shares | Fiscal year 2016: 38.62 million shares | Fiscal year 2015: 30.66 million shares | Fiscal year 2014: 20.37 million shares | Fiscal year 2013: 1.38 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: